Vanessa Suñé Mattevi

Prof. Dr. Vanessa Suñé Mattevi

Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
RLRosmeri K. Lazzaretti
Rosmeri K. Lazzaretti
AGAline S. Gasparotto
Aline S. Gasparotto
MSMarina G. de M. Sassi
Marina G. de M. Sassi
CPCarísi A. Polanczyk
Carísi A. Polanczyk
RKRegina Kuhmmer
Regina Kuhmmer
VMVanessa Suñé Mattevi
Vanessa Suñé Mattevi
This study evaluated the impact of 9 single nucleotide polymorphisms (SNPs) in 6 candidate genes (APOB, APOA5, APOE, APOC3, SCAP, and LDLR) over dyslipidemia in HIV‐infected patients on stable antiretroviral therapy (ART) with undetectable viral loads. Blood samples were collected from 614 patients at reference services in the cities of Porto Alegre, Pelotas, and Rio Grande in Brazil. The SNPs were genotyped by conventional polymerase chain reaction (PCR) and real‐time PCR. The prevalence of dyslipidemia was particularly high among the protease inhibitors‐treated patients (79%). APOE (rs429358 and rs7412) genotypes and APOA5 −1131T>C (rs662799) were associated with plasma triglycerides (TG) and low‐density‐lipoprotein cholesterol levels (LDL‐C). The APOA5 −1131T>C (rs662799) and SCAP 2386A>G (rs12487736) polymorphisms were significantly associated with high‐density‐lipoprotein cholesterol levels. The mean values of the total cholesterol and LDL‐C levels were associated with both the APOB SP Ins/Del (rs17240441) and APOB XbaI (rs693) polymorphisms. In conclusion, our data support the importance of genetic factors in the determination of lipid levels in HIV‐infected individuals. Due to the relatively high number of carriers of these risk variants, studies to verify treatment implications of genotyping before HAART initiation may be advisable to guide the selection of an appropriate antiretroviral therapy regimen.

13 March 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
CSCarmela Farias da Silva
Carmela Farias da Silva
MZMarília Remuzzi Zandoná
Marília Remuzzi Zandoná
MVMárcia R Vitolo
Márcia R Vitolo
PCPaula Dal Bó Campagnolo
Paula Dal Bó Campagnolo
LRLiane Rotta
Liane Rotta
VMVanessa Suñé Mattevi
Vanessa Suñé Mattevi
Background: Our goal was to analyze the association of the fat mass and obesity- associated (FTO) gene rs9939609 variant (T/A) with the anthropometric and dietary intake phenotypes related to obesity in Brazilian children. Methods: We analyzed the association of this single nucleotide polymorphism (SNP) with phenotypes related to the accumulation of body mass in a cohort of 348 children followed from the time of birth until 8 years old and then replicated the main findings in an independent schoolchildren sample (n = 615). Results: At the age of 4, we observed a significant association between the A/A genotype and a higher mean BMI Z-score (P = 0.036). At the age of 8, the A/A individuals still presented with a higher BMI Z-score (P = 0.011) and with marginal differences in the volume of subcutaneous fat (P = 0.048). We replicated these findings in the schoolchildren sample, which showed that those with at least one copy of the A allele presented with a higher BMI Z-score (P = 0.029) and volume of subcutaneous fat (P = 0.016). Conclusion: Our results indicate that this FTO variant is associated with increased body mass and subcutaneous fat in Brazilian children beginning at the age of 4.

23 March 2016 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
MZM. R. Zandoná
M. R. Zandoná
CSC. N. Sangalli
C. N. Sangalli
PCP. D. B. Campagnolo
P. D. B. Campagnolo
MVMárcia R Vitolo
Márcia R Vitolo
SASilvana Almeida
Silvana Almeida
VMVanessa Suñé Mattevi
Vanessa Suñé Mattevi

1 September 2012 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
LTLisiane Turatti
Lisiane Turatti
ESEduardo Sprinz
Eduardo Sprinz
RLRosmeri K. Lazzaretti
Rosmeri K. Lazzaretti
RKRegina Kuhmmer
Regina Kuhmmer
GAGrasiela Agnes
Grasiela Agnes
VMVanessa Suñé Mattevi
Vanessa Suñé Mattevi
Highly active antiretroviral therapy (HAART) has increased the survival of HIV-infected patients. However, adverse effects play a major role in adherence to HAART. Some protease inhibitors (mainly atazanavir and indinavir) act as inhibitors of uridine diphosphate-glucuronosyltransferase (UGT1A1), the enzyme responsible for hepatic conjugation of bilirubin. Variations in the promoter region of the UGT1A1 gene (UGT1A1*28, rs8175347) can influence bilirubin plasma levels, modulating the susceptibility to hyperbilirubinemia. Aiming to analyze the association between UGT1A1*28 allele and hyperbilirubinemia in individuals exposed to HAART, we evaluated 375 HIV-positive individuals on antiretroviral therapy. Individuals carrying the UGT1A1*28 allele had a higher risk of developing severe hyperbilirubinemia [prevalence ratio (PR)=2.43, 95% confidence interval (CI) 1.08–5.45, p=0.032] as well as atazanavir users (PR=7.72, 95% CI=3.14–18.98, p<0.001). This is the first description of such an association in Brazilian HIV patients, which shows that in African-American and Euroamerican HAART users, the UGT1A1*28 allele also predisposes to severe hyperbilirubinemia, especially in those exposed to atazanavir.

1 December 2015 in Clinical Biochemistry
Verified
Journal Article
Closed access
RMRaquel C.K. Miranda
Raquel C.K. Miranda
SVSilvia B. Vetter
Silvia B. Vetter
JGJúlia P. Genro
Júlia P. Genro
PCPaula D.B. Campagnolo
Paula D.B. Campagnolo
VMVanessa Suñé Mattevi
Vanessa Suñé Mattevi
SASilvana Almeida
Silvana Almeida

1 November 2013 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MZMarília Remuzzi Zandoná
Marília Remuzzi Zandoná
RRRaquel Olmedo Rodrigues
Raquel Olmedo Rodrigues
GAGabriela Albiero
Gabriela Albiero
PCPaula Dal Bó Campagnolo
Paula Dal Bó Campagnolo
MVMárcia R Vitolo
Márcia R Vitolo
VMVanessa Suñé Mattevi
Vanessa Suñé Mattevi
To assess the association of single nucleotide polymorphisms (SNPs) in five genes - leptin, leptin receptor (LEPR), adiponectin (APM1), peroxisome proliferator-activated receptor gamma (PPARG) and uncoupling protein 1 - with anthropometric, metabolic, and dietary parameters in a Southern Brazilian cohort of 325 children followed up from birth to 4 years old. SNPs were analyzed using polymerase chain reaction-based procedures, and their association with phenotypes was evaluated by t-test, analysis of variance, and general linear models. LEPR223Arg allele (rs1137101) was associated with higher daily energy intake at 4 years of age (P = 0.002; Pcorrected = 0.024). PPARG 12Ala-carriers (rs1801282) presented higher glucose levels than Pro/Pro homozygotes (P = 0.007; Pcorrected = 0.042). Two of the six studied SNPs presented consistent associations, showing that it is already possible to detect the influences of genetic variants on susceptibility to overweight in 4-year-old children.